Clinical and immune responses in advanced colorectal cancer patients treated with anti-idiotype monoclonal antibody vaccine that mimics the carcinoembryonic antigen

Clinical Cancer Research

Volumn 3, Issue 8, 1997, Pages 1267-1276

  Foon, Kenneth A ^a,b   John, William J ^a   Chakraborty, Mala ^a   Sherratt, Amanda ^a   Garrison, Juanita ^a   Flett, Melissa ^a   Bhattacharya Chatterjee, Malaya ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIIDIOTYPIC ANTIBODY; CARCINOEMBRYONIC ANTIGEN; CISPLATIN; FLUOROURACIL; FOLINIC ACID; INTERFERON; LEVAMISOLE; MITOMYCIN; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; HUMAN; IMMUNE RESPONSE; MALE; PRIORITY JOURNAL; VACCINATION;

ADULT; AGED; ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODIES, HETEROPHILE; ANTIBODIES, MONOCLONAL; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; AUTOANTIBODIES; CANCER VACCINES; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PATIENT SELECTION; SURVIVAL ANALYSIS; T-LYMPHOCYTES; TIME FACTORS;

EID: 0030746260     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Gold, P., and Freedman, S. O. Demonstration of tumor specific antigens in human colonie carcinomata by immunological tolerance and absorption techniques. J. Exp. Med., 121: 439-462, 1965.
2. Primus, F. J., Newell, K. D., Blue, A., and Goldenberg, D. M., Immunological heterogeneity of carcinoembryonic antigen distinguished by monoclonal antibodies. Cancer Res., 43: 686-692, 1983.
3. Hansen, H. J., Goldenberg, D. M., Newman, E. S., Grebenau, R., and Sharkey, R. M., Characterization of second-generation monoclonal antibodies against carcinoembryonic antigen. Cancer (Phila.), 71: 3478-3485, 1993.
4. Kuroki, M., Arakawa, F., Haruno, M., Murakami, M., Wakisaka, M., Higuchi, H., Oikawa, S., Nakazato, H., and Matsuoka, Y. Biochemical characterization of 25 distinct carcinoembryonic antigen (CEA) epitopes recognized by 57 monoclonal antibodies and categorized into seven groups in terms of domain structure of the CEA molecule. Hybridoma, 11: 391-407, 1992.
5. Goldenberg, D. M. Monoclonal antibodies in cancer detection and therapy. Am. J. Med., 94: 297-312, 1993.
6. Pressman, D., Ming, C. T., and Grossberg, A. L. Carcinoembryonic antigen-binding immunoglobulin isolated from normal human serum by affinity chromatography. J. Natl. Cancer Inst., 62: 1367-1371, 1979.
7. Kapsopoulou-Dominos, K., and Anderer, F. A. Circulating carcinoembryonic antigen immune complexes in sera of patients with carcinomata of the gastrointestinal tract. Clin. Exp. Immunol., 35: 190-195, 1979.
8. Kapsopoulou-Dominos, K., and Anderer, F. A. An approach to the routine estimation of circulating carcinoembryonic antigen immune complexes in patients with carcinomata of the gastrointestinal tract. Clin. Exp. Immunol., 37: 25-32, 1979.
9. Lejtenyi, C. M., Freedman, S. O., and Gold, P. Response of lymphocytes from patients with gastrointestinal cancer to the carcinoembryonic antigen of the human digestive system. Cancer (Phila.), 28: 115-120, 1971.
10. Orefice, S., Fossati, G., Pietrojusti, E., and Bonfanti, G. Delayed cutaneous hypersensitivity reaction to carcinoembryonic antigen in cancer patients. Tumori, 68: 473-475, 1982.
11. Lindenmann, J. Speculations on idiotypes and homobodies. Ann. Immunol. (Paris), 124: 171-184, 1973.
12. Jerne, N. K. Towards a network theory of the immune system. Ann. Immunol. (Paris), 125C: 373-389, 1974.
13. Paxton, R. J., Mooser, G., Pande, H., Lee, T. D., and Shivley, J. E. Sequence analysis of carcinoembryonic antigen: identification of glycosylation sites and homology with the immunoglobulin super-gene family. Proc. Natl. Acad. Sci. USA, 84: 920-924, 1987.
14. Thompson, J., and Zimmerman, W. The carcinoembryonic antigen gene family: structure, expression, and evolution. Tumour Biol., 9: 63-83, 1988.
15. Benchimol, S., Fuks, A., Jothy, S., Beauchemia, N., Shirota, K., and Stanners, C. Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule. Cell, 57: 327-334, 1989.
16. Oikawa, S., Inuzuka, C., Kuroki, M., Matsuoka, Y., Kosaki, G., and Nakazato, H. Cell adhesion activity of non-specific cross-reacting antigen (NCA) and carcinoembryonic antigen (CEA) expressed on CHO cell surface: homophilic and heterophilic adhesion. Biochem. Biophys. Res. Commun., 164: 39-45, 1989.
17. Cazenave, P. A. Idiotypic-anti-idiotypic regulation of antibody synthesis in rabbits. Proc. Natl. Acad. Sci. USA, 74: 5122-5125, 1977.
18. Bona, C., Herber-Katz, E., and Paul, W. E. Idiotype-anti-idiotype regulation. I. Immunization with a levan-binding myeloma protein leads to the appearance of auto-anti-(anti-idiotype) antibodies and to the activation of silent clones. J. Exp. Med., 153: 951-967, 1981.
19. Tsujisaki, M., Imai, K., Tokuchi, S., Hanzawa, Y., Ishida, T., Kitagawa, H., Hinoda, Y., and Yachi, A. Induction of antigen-specific immune response with use of anti-idiotypic monoclonal antibodies to anti-carcinoembryonic antigen antibodies. Cancer Res 51: 2599-2604, 1991.
20. Tsujisaki, M., Hinoda, Y., Tokuchi, S., Hanzawa, Y., Arimura, Y., Masuya, J., Kitagawa, H., Okochi, E., Shimamura, T., Hamuro, J., Imai, K., and Yachi, A. The analysis of internal image-bearing anti-idiotypic monoclonal antibody in relation to carcinoembryonic antigen. J. Immunol., 150: 508-516, 1993.
21. Durrant, L. G., Denton, G. W. L., Jacobs, E., Mee, M., Moss, R., Austin, E. B., Baldwin, R. W., Hardcastle, J. D., and Robins, R. A. An idiotypic replica of carcinoembryonic antigen inducing cellular and humoral responses directed against human colorectal tumors. Int. J. Cancer, 50: 811-816, 1992.
22. Gaida, F-J., Fenger, U., Wagener, C., and Neumaier, M. A monoclonal anti-idiotypic antibody bearing the image of an epitope specific to the human carcinoembryonic antigen. Int. J. Cancer 51: 459-465, 1992.
23. de Moraes, J. Z., Carneiro, C. R. W., Buchegger, F., Mach, J-P., and Lopes, J. D. Induction of an immune response through the idiotypic network with monoclonal anti-idiotype antibodies in the carcinoembryonic antigen system. J. Cell. Biochem., 50: 324-335, 1992.
24. Austin, E. B., Robins, R. A., Baldwin, R. W., and Durrant, L. G. Introduction of delayed hypersensitivity to human tumor cells with a human monoclonal anti-idiotypic antibody. J. Natl. Cancer Inst., 83: 1245-1248, 1991.
25. Losman, M. J., Novick, K. E., Goldenberg, D. M., and Monestier, M. Mimicry of a carcinoembryonic antigen epitope by a rat monoclonal anti-idiotype antibody. Int. J. Cancer., 56: 580-584, 1994.
26. Irvine, K., and Schlom, J. Induction of delayed-type hypersensitivity responses by monoclonal anti-idiotypic antibodies to tumor cells expressing carcinoembryonic antigen and tumor-associated glycoprotein-72. Cancer Immunol. Immunother., 36: 281-292, 1993.
27. Losman, M. J., Monestier, M., Hansen, H. J., and Goldenberg, D. M. Baboon anti-idiotype antibodies mimic a carcinoembryonic antigen epitope. Int. J. Cancer, 46: 310-314, 1990.
28. Koprowski H., Steplewski, Z., Mitchell, K., Herlyn, M., Herlyn, D., and Fuhrer, P. Colorectal carcinoma antigens detected by hybridoma antibodies. Somatic Cell Genet., 5: 957-971, 1979.
29. Bhattacharya-Chatterjee, M., Mukerjee, S., Biddle, W., Foon, K. A., and Köhler, H. Murine monoclonal anti-idiotype antibody as a potential network antigen for human carcinoembryonic antigen. J. Immunol., 145: 2758-2765, 1990.
30. Chakraborty, M., Foon, K. A., Köhler, H., and Bhattacharya-Chatterjee, M. Murine monoclonal anti-idiotype antibody induces a specific antibody response to human carcinoembryonic antigen (CEA) in cynomolgus monkeys. FASEB J., A504, 1994.
31. Foon, K. A., Chakraborty, M., John, W. J., Sherratt, A., Köhler, H., and Bhattacharya-Chatterjee, M. Immune response to the carcinoembryonic antigen in patients treated with an anti-idiotype antibody vaccine. J. Clin. Invest., 96: 334-342, 1995.
32. Bhattacharya-Chatterjee, M., Pride, M. W., Seon, B. K., and Köhler, H. Idiotype vaccines against human T-cell acute lymphoblastic leukemia (TALL). I. Generation and characterizations of biologically active monoclonal anti-idiotypes. J. Immunol., 5: 562-573, 1987.
33. Bhattacharya-Chatterjee, M., Chatterjee, S. K., Vasile, S., Seon, B. K., and Köhler, H. Idiotype vaccines against T-cell leukemia. II. Generation and characterization of monoclonal idiotype cascade (Ab1, Ab2 and Ab3). J. Immunol., 141: 1398-1403, 1988.
34. Khazaeli, M. B., Saleh, M. N., Wheeler, R. H., Huster, W. J., Holden, H., Carrano, R., and LoBuglio, A. F. Phase I trial of multiple large doses of murine monoclonal antibody CO17-1A. II. Pharmacokinetics and immune response. J. Natl. Cancer Inst., 80: 937-942, 1988.
35. Kaplan, E. L., and Meier, P. Non-parametric estimation from incomplete observations. J. Am. Stat. Assoc., 53: 457-481, 1995.
36. Rothenberg, M. L., Eckardt, J. R., Kuhn, J. G., Burris, H. A., Nelson, J., Hilsenbeck, S. G., Rodriguez, G. I., Thurman, A. M., Smith, L. S., Eckhardt, S. G., Weiss, G. R., Elfring, G. L., Rinaldi, D. A., Schaaf, L. J., and Von Hoff, D. D. Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer. J. Clin Oncol., 14: 1128-1135, 1996.
37. Tsang, K. Y., Zaremba, S., Nieroda, C. A., Zhu, M. Z., Hamilton, J. M., and Schlom, J. Generation of human cytotoxic T cells specific for human carcinoembryonic antigen epitopes from patients immunized with recombinant vaccinia-CEA vaccine. J. Natl. Cancer Inst., 87: 982-990, 1995.
38. Mittleman, A., Chen, Z. J., Kageshita, T., Yang, H., Yamada, M., Baskind, P., Goldberg, N., Puccio, C., Ahmed, T., Arlin, Z., et al. Active specific immunotherapy in patients with melanoma: a clinical trial with mouse anti-idiotypic monoclonal antibodies elicited with syngeneic anti-high-molecular-weight-melanoma-associated antigen monoclonal antibodies. J. Clin. Invest., 86: 2136-2144, 1990.
39. Mittleman, A., Chen, Z. J., Yang, H., Wong, G. Y., and Ferrone, S. Human high molecular weight melanoma-associated antigen (HMW-MAA) mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: induction of humoral anti-HMW-MAA immunity and prolongation of survival in patients with stage IV melanoma. Proc. Natl. Acad. Sci. USA. 89: 466-470, 1992.
40. Kwak, L., Campbell, M., Czerwinski, B., Hart, S., Miller, R., and Levy, R. Induction of immune responses in patients with B cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors. N. Engl. J. Med., 327: 1209-1215, 1992.
41. Foon, K. A., Oseroff, A. R., Vaickus, L., Greenberg, S. J., Russell, D., Bernstein, Z., Pincus, S., Köhler, H., Seon, B. K., Tahaoglu, E., Beers, T., Chakraborty, M., and Bhattacharya-Chatterjee, M. Immune response in patients with T-cell lymphoma treated with an anti-idiotype antibody mimicking a highly restricted T-cell antigen. Clin. Can. Res., 1: 1285-1294, 1995.